Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001070081-17-000077
Filing Date
2017-04-28
Accepted
2017-04-27 19:12:22
Documents
5
Period of Report
2017-06-09
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A ptctproxy4282017.htm DEF 14A 1184775
2 cdagraphica02.jpg GRAPHIC 146036
3 g198666.jpg GRAPHIC 2956
4 g683229.jpg GRAPHIC 6822
5 ptc.jpg GRAPHIC 8644
  Complete submission text file 0001070081-17-000077.txt   1397698
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 17791011
SIC: 2834 Pharmaceutical Preparations